临床外科杂志 ›› 2026, Vol. 34 ›› Issue (5): 534-538.doi: 10.3969/j.issn.1005-6483.20250265

• 论著 • 上一篇    下一篇

胰腺癌病人血清微小RNA-451、微小RNA-15a、微小RNA-133b表达及其临床意义

  

  1. 056002  河北邯郸,邯郸市第一医院普外三科(张鹏),急诊科(张强),药学部(李晓利),普外七科(刘云)
  • 收稿日期:2025-03-21 接受日期:2025-03-21 出版日期:2026-05-20 发布日期:2026-05-20
  • 通讯作者: 刘云,Email:sswikk@163.com
  • 基金资助:
    邯郸市科学技术研究与发展计划项目(23422083260)

Expression and clinical significance of serum microRNA-451,microRNA-15a,microRNA-133b in patients with pancreatic cancer

  1. Department of General Surgery 3,the Handan First Hospital,Handan 056002,China
  • Received:2025-03-21 Accepted:2025-03-21 Online:2026-05-20 Published:2026-05-20

摘要: 目的  探讨胰腺癌病人血清微小RNA(miR)-451、miR-15a、miR-133b的表达及其临床意义。方法 2021年1月~2024年10月收治的195例胰腺癌病人为胰腺癌组,同期本院体检健康的205例志愿者为对照组。qRT-PCR法检测血清miR-451、miR-15a、miR-133b的表达水平;记录受试者一般资料及病人临床特征;多因素Logistic回归分析影响胰腺癌发生的因素;受试者工作特征(ROC)曲线分析血清miR-451、miR-15a、miR-133b对胰腺癌的诊断价值。结果 对照组和胰腺癌组身体质量指数(BMI)、饮酒史、年龄、性别、吸烟史比较,差异无统计学意义(P>0.05);胰腺癌组总胆固醇(TC)和甘油三酯(TG)水平分别为(1.92±0.28)mmol/L、(1.66±0.29)mmol/L,较对照组的(1.85±0.22)mmol/L、(1.35±0.28)mmol/L升高,差异有统计学意义(P<0.05);胰腺癌组血清miR-451、miR-15a、miR-133b水平分别为(0.84±0.12)、(0.82±0.16)、(0.85±0.15),较对照组的(1.03±0.16)、(1.01±0.19)、(1.02±0.16)均降低,差异有统计学意义(P<0.05);血清miR-451、miR-15a、miR-133b水平升高是患胰腺癌的保护因素(P<0.05);miR-451、miR-15a、miR-133b单独及联合诊断胰腺癌的AUC分别为0.855、0.766、0.790、0.941,三者联合优于各自单独诊断(Z=5.681、7.806、7.314,P<0.001);不同年龄、肿瘤最大径、性别、分化程度的胰腺癌病人血清miR-451、miR-15a、miR-133b水平比较,差异无统计学意义(P>0.05);有淋巴结转移、TNM分期Ⅲ~Ⅳ期、远处转移的胰腺癌病人血清miR-451、miR-15a、miR-133b低表达的比例高于高表达比例(P<0.05)。结论 胰腺癌病人血清miR-451、miR-15a、miR-133b水平均降低,三者对胰腺癌具有一定的诊断价值,且与病人的临床病理特征有关。

关键词: 胰腺癌, 微小RNA-451, 微小RNA-15a, 微小RNA-133b, 诊断价值, 临床病理特征

Abstract: Objective To investigate the expression and clinical significance of serum microRNA-451 (miR-451),miR-15a,miR-133b in patients with pancreatic cancer.Methods Between January 2021 and October 2024,195 patients with pancreatic cancer admitted to our hospital were regarded as the observation object,namely pancreatic cancer group,and 205 healthy volunteers who underwent physical examinations in our hospital during the same period were selected as the control group.The qRT-PCR method was performed to detect serum miR-451,miR-15a,and miR-13b.The general information of the subjects and the clinical features of the patients were recorded.Multivariate logistic regression was performed to analyze the factors affecting the occurrence of pancreatic cancer.ROC curve was used to analyze the diagnostic value of serum miR-451,miR-15a and miR-133b in pancreatic cancer.Results There was no prominent difference in BMI,drinking history,age,gender,and smoking history between control group and pancreatic cancer group (P>0.05).The levels of total cholesterol (TC) and triglycerides (TG) in the pancreatic cancer group were (1.92±0.28) mmol/L and (1.66±0.29) mmol/L respectively,which were higher than those in the control group [(1.85±0.22) mmol/L and (1.35±0.28) mmol/L].The difference was statistically significant (P<0.05).The levels of serum miR-451,miR-15a and miR-133b in the pancreatic cancer group were (0.84±0.12),(0.82±0.16),and (0.85±0.15),respectively,which were lower than those in the control group [(1.03±0.16),(1.01±0.19),and (1.02±0.16)].The difference was statistically significant (P<0.05).Elevated levels of serum miR-451,miR-15a and miR-133b are protective factors for pancreatic cancer (P<0.05);The AUCs of miR-451,miR-15a and miR-133b in the diagnosis of pancreatic cancer alone and in combination were 0.855,0.766,0.790,and 0.941,respectively.The combination of the three was superior to the individual diagnosis (Z=5.681、7.806、7.314,P<0.001).There was no prominent difference in serum miR-451,miR-15a,and miR-133b among pancreatic cancer patients of different ages,tumor size,gender,and differentiation degree (P>0.05).In pancreatic cancer patients with lymph node metastasis,TNM stage Ⅲ-Ⅳ,and distant metastasis,the proportions of low expression of serum miR-451,miR-15a,and miR-133b were higher than the proportions of high expression (P<0.05).Conclusion Serum miR-451,miR-15a,miR-133b in patients with pancreatic cancer are decreased.The three factors have certain diagnostic value for pancreatic cancer,and are related to the clinical pathological features.

Key words: pancreatic cancer, microRNA-451, microRNA-15a, microRNA-133b, diagnostic value, clinical pathological features

[1] 赵浩男 王嘉敏 金若天. 血清C-X-C趋化因子受体7和溶质载体家族7成员11与胃癌临床病理特征及病人预后的关系[J]. 临床外科杂志, 2026, 34(5): 518-522.
[2] 王若雪 刘昕 李晓青 徐艺泽 郑冬 马策 安云恒. 血清半乳糖凝集素-3和基质细胞衍生因子-1联合超声弹性成像对甲状腺乳头状癌的诊断价值[J]. 临床外科杂志, 2026, 34(3): 267-271.
[3] 李建刚 吴士兴 徐新建 刘超. 基于基因表达及病理特征对可切除胰腺癌1年预后模型的构建[J]. 临床外科杂志, 2026, 34(3): 306-310.
[4] 赵攀, 张明, 吴健, 肖刘敏, 程济明, 张子龙. 胃癌组织中血小板反应蛋白2和富含半胱氨酸的酸性分泌蛋白的表达与胃癌病人氧化应激、临床病理特征和预后的关系[J]. 临床外科杂志, 2026, 34(1): 69-73.
[5] 方丽 田云霄 高庆利 牛广旭. 细胞周期蛋白B2、细胞周期蛋白E表达与肝癌病人临床病理特征及5年生存率的关系分析[J]. 临床外科杂志, 2025, 33(9): 981-984.
[6] 孙宇 郝立政 胡晓立. 血清G蛋白信号调节因子2、适配器相关蛋白复合物3亚基mu2与早期结直肠癌病人临床病理特征及预后的相关性分析[J]. 临床外科杂志, 2025, 33(6): 623-627.
[7] 李永 汪鸿波 李雷. 结直肠癌组织微小核糖核酸-30c-5p、非酶几丁质酶-3样蛋白-1表达及与其临床病理特征、淋巴结转移的关系[J]. 临床外科杂志, 2025, 33(6): 628-631.
[8] 王艺睿 吴河水 周颖珂. 胰腺癌病人全程营养管理的临床策略与进展[J]. 临床外科杂志, 2025, 33(12): 1250-1254.
[9] 刘雅琳 梁金屏 马旭. 血清甲状腺球蛋白抗体、促甲状腺素水平与分化型甲状腺癌病人临床病理特征的相关性及对术后转移的预测价值[J]. 临床外科杂志, 2025, 33(12): 1271-1275.
[10] 王少华 汪春荣 黄晓燕 刘勇彬 刘志新. 低剂量螺旋CT联合血清热休克蛋白70、骨膜蛋白在肺癌早期诊断中的应用价值[J]. 临床外科杂志, 2025, 33(10): 1069-1072.
[11] 侯钰坤, 汪兴龙, 杨尹默, 田孝东. 美国国立综合癌症网络临床实践指南:胰腺癌(2025.V1)更新解读[J]. 临床外科杂志, 2025, 33(1): 49-51.
[12] 陈应凯 严明. 血浆外泌体miR-93对恶性胸腔积液的诊断价值[J]. 临床外科杂志, 2024, 32(9): 932-935.
[13] 何朝滨 李升平. 不可逆电穿孔治疗胰腺癌[J]. 临床外科杂志, 2024, 32(7): 673-676.
[14] 徐业成 傅德良. 胰腺全切除术在胰腺癌治疗中的应用[J]. 临床外科杂志, 2024, 32(7): 677-679.
[15] 黄如敬 鲁洪岭 吴超 杨洪娟 尹晓明 赵阳 康华薇 田菲 孙云川. 非小细胞肺癌病人血清miR-326和miR-623表达与临床病理特征及预后的关系[J]. 临床外科杂志, 2024, 32(7): 706-710.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 涂儒鸿;黄昌明. 腹腔镜胃癌根治术淋巴结清扫技巧[J]. 临床外科杂志, 2016, 24(11): 809 .
[2] 陈凛;崔建新. 胃癌术后复发与再手术[J]. 临床外科杂志, 2016, 24(11): 813 .
[3] 杨钦;张再重;王烈. 空肠间置术在Siewert Ⅱ型食管胃结合部腺癌中的应用[J]. 临床外科杂志, 2016, 24(11): 816 .
[4] 应敏刚;杨春康. 腹腔镜胃癌根治术并发症的防治策略[J]. 临床外科杂志, 2016, 24(11): 819 .
[5] 石汉平. 胃癌围手术期营养治疗[J]. 临床外科杂志, 2016, 24(11): 821 .
[6] 吴川清;刘炜圳;帅晓明;等. 超声内镜在胃癌术前诊断中的应用分析[J]. 临床外科杂志, 2016, 24(11): 828 .
[7] 王维君;那光玮;何科基;等. 根治性淋巴结清扫联合脾切除在残胃癌手术中的临床意义探究[J]. 临床外科杂志, 2016, 24(11): 835 .
[8] 李晓辉;金太欣;邵永胜 . 升结肠回盲部肿瘤侵犯乙状结肠22例治疗体会[J]. 临床外科杂志, 2016, 24(11): 841 .
[9] 周振宇;汪路明;王一青;等. 肺部多发结节468例诊疗分析[J]. 临床外科杂志, 2016, 24(11): 865 .
[10] 张重捷;陈杰;邹奇;等. 两种微创手术治疗胆囊结石合并胆总管结石的临床效果比较[J]. 临床外科杂志, 2016, 24(11): 869 .